vs
Side-by-side financial comparison of Enpro Inc. (NPO) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
Enpro Inc. is the larger business by last-quarter revenue ($295.4M vs $148.5M, roughly 2.0× OPKO HEALTH, INC.). Enpro Inc. runs the higher net margin — -10.8% vs -21.1%, a 10.2% gap on every dollar of revenue. On growth, Enpro Inc. posted the faster year-over-year revenue change (14.3% vs -19.2%). Over the past eight quarters, Enpro Inc.'s revenue compounded faster (7.1% CAGR vs -7.5%).
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
NPO vs OPK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.4M | $148.5M |
| Net Profit | $-32.0M | $-31.3M |
| Gross Margin | 42.1% | 43.1% |
| Operating Margin | 11.2% | -25.8% |
| Net Margin | -10.8% | -21.1% |
| Revenue YoY | 14.3% | -19.2% |
| Net Profit YoY | -330.2% | -322.8% |
| EPS (diluted) | $-1.50 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.4M | $148.5M | ||
| Q3 25 | $286.6M | $151.7M | ||
| Q2 25 | $288.1M | $156.8M | ||
| Q1 25 | $273.2M | $150.0M | ||
| Q4 24 | $258.4M | $183.6M | ||
| Q3 24 | $260.9M | $173.6M | ||
| Q2 24 | $271.9M | $182.2M | ||
| Q1 24 | $257.5M | $173.7M |
| Q4 25 | $-32.0M | $-31.3M | ||
| Q3 25 | $21.6M | $21.6M | ||
| Q2 25 | $26.4M | $-148.4M | ||
| Q1 25 | $24.5M | $-67.6M | ||
| Q4 24 | $13.9M | $14.0M | ||
| Q3 24 | $19.8M | $24.9M | ||
| Q2 24 | $26.7M | $-10.3M | ||
| Q1 24 | $12.5M | $-81.8M |
| Q4 25 | 42.1% | 43.1% | ||
| Q3 25 | 41.9% | 32.9% | ||
| Q2 25 | 43.3% | 31.5% | ||
| Q1 25 | 43.3% | 28.4% | ||
| Q4 24 | 42.3% | 46.1% | ||
| Q3 24 | 42.3% | 23.1% | ||
| Q2 24 | 43.8% | 28.4% | ||
| Q1 24 | 41.2% | 24.2% |
| Q4 25 | 11.2% | -25.8% | ||
| Q3 25 | 14.3% | 31.7% | ||
| Q2 25 | 15.9% | -38.3% | ||
| Q1 25 | 15.3% | -44.8% | ||
| Q4 24 | 12.5% | -18.0% | ||
| Q3 24 | 13.1% | 8.2% | ||
| Q2 24 | 17.7% | -33.9% | ||
| Q1 24 | 10.9% | -41.2% |
| Q4 25 | -10.8% | -21.1% | ||
| Q3 25 | 7.5% | 14.3% | ||
| Q2 25 | 9.2% | -94.7% | ||
| Q1 25 | 9.0% | -45.1% | ||
| Q4 24 | 5.4% | 7.6% | ||
| Q3 24 | 7.6% | 14.3% | ||
| Q2 24 | 9.8% | -5.7% | ||
| Q1 24 | 4.9% | -47.1% |
| Q4 25 | $-1.50 | $-0.04 | ||
| Q3 25 | $1.01 | $0.03 | ||
| Q2 25 | $1.25 | $-0.19 | ||
| Q1 25 | $1.15 | $-0.10 | ||
| Q4 24 | $0.65 | $0.02 | ||
| Q3 24 | $0.94 | $0.03 | ||
| Q2 24 | $1.27 | $-0.01 | ||
| Q1 24 | $0.59 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.7M | $364.4M |
| Total DebtLower is stronger | $655.3M | $344.0M |
| Stockholders' EquityBook value | $1.5B | $1.3B |
| Total Assets | $2.7B | $1.9B |
| Debt / EquityLower = less leverage | 0.42× | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.7M | $364.4M | ||
| Q3 25 | $132.9M | $412.0M | ||
| Q2 25 | $107.1M | $267.3M | ||
| Q1 25 | $240.3M | $428.8M | ||
| Q4 24 | $236.3M | $426.6M | ||
| Q3 24 | $206.9M | $400.1M | ||
| Q2 24 | $175.9M | $40.6M | ||
| Q1 24 | $163.9M | $75.6M |
| Q4 25 | $655.3M | $344.0M | ||
| Q3 25 | — | $344.2M | ||
| Q2 25 | — | $343.3M | ||
| Q1 25 | — | $439.2M | ||
| Q4 24 | $640.1M | $437.2M | ||
| Q3 24 | — | $441.0M | ||
| Q2 24 | — | $201.9M | ||
| Q1 24 | $644.9M | $350.1M |
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.5B | $1.3B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.4B | $1.4B | ||
| Q1 24 | $1.4B | $1.3B |
| Q4 25 | $2.7B | $1.9B | ||
| Q3 25 | $2.4B | $2.0B | ||
| Q2 25 | $2.4B | $2.0B | ||
| Q1 25 | $2.5B | $2.1B | ||
| Q4 24 | $2.5B | $2.2B | ||
| Q3 24 | $2.5B | $2.3B | ||
| Q2 24 | $2.5B | $2.0B | ||
| Q1 24 | $2.5B | $2.0B |
| Q4 25 | 0.42× | 0.27× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | 0.45× | 0.32× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | 0.46× | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-25.9M |
| Free Cash FlowOCF − Capex | — | $-28.6M |
| FCF MarginFCF / Revenue | — | -19.3% |
| Capex IntensityCapex / Revenue | 4.1% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.9M | ||
| Q3 25 | $65.3M | $-34.6M | ||
| Q2 25 | $52.2M | $-83.4M | ||
| Q1 25 | $21.0M | $-34.6M | ||
| Q4 24 | $59.4M | $-44.4M | ||
| Q3 24 | $54.0M | $-77.1M | ||
| Q2 24 | $43.2M | $-26.4M | ||
| Q1 24 | $6.3M | $-35.6M |
| Q4 25 | — | $-28.6M | ||
| Q3 25 | $53.4M | $-37.8M | ||
| Q2 25 | $42.3M | $-86.7M | ||
| Q1 25 | $13.0M | $-37.7M | ||
| Q4 24 | $49.1M | $-49.8M | ||
| Q3 24 | $48.3M | $-85.0M | ||
| Q2 24 | $38.3M | $-33.7M | ||
| Q1 24 | $-1.9M | $-40.0M |
| Q4 25 | — | -19.3% | ||
| Q3 25 | 18.6% | -24.9% | ||
| Q2 25 | 14.7% | -55.3% | ||
| Q1 25 | 4.8% | -25.2% | ||
| Q4 24 | 19.0% | -27.1% | ||
| Q3 24 | 18.5% | -49.0% | ||
| Q2 24 | 14.1% | -18.5% | ||
| Q1 24 | -0.7% | -23.0% |
| Q4 25 | 4.1% | 1.8% | ||
| Q3 25 | 4.2% | 2.1% | ||
| Q2 25 | 3.4% | 2.1% | ||
| Q1 25 | 2.9% | 2.1% | ||
| Q4 24 | 4.0% | 2.9% | ||
| Q3 24 | 2.2% | 4.6% | ||
| Q2 24 | 1.8% | 4.0% | ||
| Q1 24 | 3.2% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | 3.02× | -1.60× | ||
| Q2 25 | 1.98× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 4.27× | -3.17× | ||
| Q3 24 | 2.73× | -3.10× | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
